Hepatitis B
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Participants must be aged 18 years or above, with no restriction on gender; 2.Individuals requiring HBV screening, diagnosis, treatment, and follow-up; 3.Voluntary participation in this study and signed informed consent form prior to the study;
Exclusion criteria
Exclusion criteria: 1.Prior confirmed diagnosis of non-HBV infection; 2.Inability to understand the study procedures or to independently provide informed consent, and having no legally authorized representative; 3.Any other condition deemed by the investigator to make the individual inappropriate for the study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The completion rate of HBV diagnosis within 2 years for populations requiring further diagnosis;The completion rate of standardized follow-up within 2 years for populations enrolled in routine management;The initiation rate of antiviral therapy within 2 years for populations meeting antiviral treatment indications;The completion rate of HBsAg test within 2 years for populations requiring HBV screening; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time interval between enrollment and completion of the first HBV marker test among participants;Health economic evaluation;Liver function normalization rate;Implementation science evaluation;Social psychosocial evaluation;Number of HBV marker tests completed by participants during the 2-year follow-up period;HBV DNA clearance rate; | — |
Countries
China
Contacts
Southern Medical University Southern Hospital